US FDA warns Cadila Pharma over drug production processes

摘要

The US Food and Drug Administration (FDA) has warned drug-maker Cadila Pharmaceuticals Ltd. that it was not following quality and manufacturing standards at one of its plants, which caused impurities in drug ingredients made there.